Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/22/2025

Cervical Cancer Screening

Introduction to Cervical Cancer Screening

  • The Centers for Disease Control and Prevention (CDC) provides guidelines for cervical cancer screening, including recommendations for Pap smear collection and timing, as well as interpretation and follow-up 1
  • The American College of Obstetricians and Gynecologists (ACOG) and the National Comprehensive Cancer Network (NCCN) also provide guidelines for cervical cancer screening, including recommendations for screening intervals and management of abnormal results 2, 3, 4

Pap Smear Collection and Timing

  • The CDC recommends that if a woman is unlikely to return for follow-up, a Pap smear can be obtained after careful removal of the discharge with a saline-soaked cotton swab 1
  • The CDC suggests that if a woman is menstruating, the Pap smear should be postponed and the woman advised to have it at the earliest opportunity 1
  • A cytobrush may be used to collect a Pap smear from pregnant women, taking care not to disrupt the mucous plug, as recommended by the CDC 1

Pap Smear Interpretation and Follow-up

  • The CDC notes that the Pap smear is not an effective screening test for STDs, but findings like PMNs can prompt additional testing 1
  • The CDC recommends that all test results, follow-up appointments, and management decisions should be clearly documented 1
  • The NCCN recommends immediate colposcopy with directed biopsy for patients with Low-grade Squamous Intraepithelial Lesion (LSIL) and positive HPV test, while the American College of Physicians-backed guidelines suggest colposcopy for all squamous lesions other than ASC-US in adults older than 30 years 2
  • HPV testing is not recommended for triage in women with LSIL as approximately 86% will be HPV positive, making it an inefficient triage strategy 5
  • The CDC recommends colposcopy with directed biopsy of any abnormal areas as the preferred approach, as well as follow-up with repeat Pap tests every 2-6 months for selected reliable patients, and immediate colposcopy and directed biopsy for required management 6

Management of Abnormal Pap Smear Results

  • For patients with severe inflammation and reactive cellular changes, a repeat Pap smear is recommended in 3 months, and any underlying infection should be treated before the repeat Pap smear 7
  • Directed biopsy of any abnormal areas on the ectocervix should be performed, as suggested by the American Academy of Family Physicians (AAFP) 8
  • The ACOG recommends an initial cervical Pap smear upon initiation of care, with repeat screening at 6 months, then annually if results are normal, and considers more frequent screening for women with previous abnormal Pap smear, after treatment for cervical dysplasia, symptomatic HIV infection, or known HPV infection 3
  • Option 1: Repeat cytology at 6 and 12 months 2
  • Option 2: HPV DNA testing for high-risk viruses at 12 months, and if HPV negative at 12 months, return to normal screening schedule 2
  • If HPV positive at 12 months, perform colposcopy 2
  • Further therapy is indicated, consisting of LEEP, cryotherapy, cold knife conization (CKC), or laser ablation 2
  • CKC is preferred for patients in whom microinvasive cervical cancer is suspected 2
  • Patients who test positive for HPV 16 or 18 should be monitored more closely as they have a higher risk of developing CIN III 2
  • Avoid excision or ablation procedures for negative findings or CIN I to prevent overtreatment 2
  • The ASCUS-LSIL Triage Study (ALTS) demonstrated the effectiveness of HPV testing, making it the most efficient approach, with the following results:

    HPV Test Result Colposcopy Referral
    Positive Refer for colposcopy
    Negative Repeat cytology in 12 months
  • If CIN2+ is diagnosed, the NCCN recommends proceeding with appropriate treatment, such as an excisional procedure like LEEP or cold-knife conization 4

Special Considerations

  • Adolescents have very high rates of spontaneous regression (>90% within 36 months), and overtreatment should be avoided, according to the ACOG 9
  • Expedited treatment is not recommended during pregnancy, as stated by the CDC 10
  • If a patient has had a negative screening result with HPV testing or cotesting within the previous 5 years, the HPV test should be repeated with or without a Pap test in 1 year instead of immediate colposcopy, as recommended by the CDC 10
  • Patient history, including previous screening results and colposcopy findings, should be considered when determining management recommendations, as recommended by the CDC 10
  • After treatment for high-grade precancer, surveillance should continue for at least 25 years, as recommended by the CDC and the ACOG 10
  • Initial post-treatment testing schedule: HPV test or cotest at 6, 18, and 30 months, as recommended by the CDC 10

Patient Education and Communication

  • The CDC recommends providing patients with printed information about Pap smears, sending a copy of the Pap smear result to the patient when available, and addressing patient misconceptions about Pap smear testing 7, 1
  • Clear communication about testing is essential, as many women believe they have had a Pap smear when they actually have not, according to the CDC 1
  • All test results, follow-up appointments, and management decisions must be clearly documented, according to the CDC and the MMWR Recommendations and Reports 11, 1

REFERENCES

2

cervical cancer screening. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2010

4

cervical cancer screening. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2014